Pharmacies can strategically invest in AI technologies to streamline operations and improve patient care while addressing cost challenges and maximizing return on investment in 2025.
Key opinion leaders provide some advice for the public regarding COVID-19 booster shots and look to the future of the pandemic.
Tackling racial disparities among health care providers can help improve disparities faced by patients.
Choosing the appropriate device and using the correct technique are critical for drug delivery to the lungs.
An overview of updated CDC ACIP recommendations for COVID-19 vaccines available through commercial channels for the 2023-2024 season.
An overview of how gene therapy has evolved since its inception, current applications, and emerging challenges.
Remission is a new emphasis and treatment goal for the management of asthma.
An overview of the use of direct oral anticoagulants as an alternative to warfarin in the treatment of left ventricular thrombus.
The relatively new combination of PD-1/PD-L1 inhibitors with VEGF inhibitors represents a promising option for patients with various malignancies.
Pharmacists play an important role in the recovery journey for patients who decide medication assisted treatment is right for them.
Pharmacy benefit managers offer mentorship, training opportunities, and professional advancement beyond what's available in traditional pharmacy careers.
Living organisms rely on iron for survival and replication. Can new research discoveries disrupt C. difficile’s ability to maintain iron homeostasis?
To make the best use of these funds to improve a hospital’s services, leaders should start planning now for these changes using the 4 following strategies.
Decentralization has already been shown to streamline clinical trials, but it also has the potential to improve the broader health care ecosystem.
PBM reforms and regulatory changes have reshaped the industry landscape.
Current guideline recommendations include various combinations of targeted therapy with immunotherapy.
Panelists discuss how recent FDA regulatory actions regarding obeticholic acid have raised concerns about its long-term safety profile and accessibility, leading health care teams to develop strategies for supporting patients through treatment transitions while navigating insurance coverage and access challenges for newer primary biliary cholangitis (PBC) therapies.
A novel collaboration between the University of Pennsylvania and US Anesthesia Partners is working to drive evidence-based change in benzodiazepine use.
Recent FDA findings highlight that a major ingredient in popular cold fighters, phenylephrine, may not offer genuine relief.
These agents are likely to become the mainstay of cancer treatment in the very near future.
For patients with type 1 and type 2 diabetes, decisions around the selection of glucose meters can be difficult as there are several brands and types of meters available.
Factor XI inhibitors show promise as a safer alternative to direct oral anticoagulants for preventing and treating thrombosis, offering similar efficacy with reduced bleeding risk.
Evidence indicates that up to 25% of all prescriptions for children could be dosed inappropriately, making it the most common type of medication administration error.
Therapeutic drug monitoring is essential with tacrolimus, which is one of the key immunosuppressive agents used after solid organ transplant.
Outpatient treatment is primarily based on patient-specific factors, whereas oseltamivir remains the therapy of choice for inpatient settings.
Pharmacists are in a strong position to identify the early warning signs of diabetes because they are often the most accessible and frequently visited members of the health care team.
Integration of these agents requires supportive care considerations for cytokine release syndrome, neurotoxicity, infection, and antigen-specific toxicities to ensure optimal care of patients with multiple myeloma receiving T-cell–engaging therapies.
Evidence-based guidelines support the safe and effective administration of Ig therapy in clinical practice.